senate · trading 2011-02-01 → 2023-08-08
*Purchases reported over roughly the last three years, weighted by the midpoint of each disclosed dollar band and marked to the latest close. Filings state a range, never a share count, so this tracks the stock rather than the position. It is not a dollar figure and it is not what this member made.
▮ buys · ▮ sells
| Date | Ticker | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2023-08-08 | ROAD | SELL | $250K–$500K | $33.94 | $110.10 2026-08-28 | -224.4% exit |
| 2022-01-31 | ROAD | SELL | $100K–$250K | $26.24 | $110.10 2026-08-28 | -319.6% exit |
| 2021-10-14 | ROAD | SELL | $50K–$100K | $34.75 | $110.10 2026-08-28 | -216.8% exit |
| 2019-02-20 | ZAYO | SELL | $250K–$500K | — | — | — exit |
| 2019-02-19 | ZAYO | SELL | $500K–$1.0M | — | — | — exit |
| 2019-02-19 | CHTR | SELL | $1.0M–$5.0M | $348.43 | $153.62 2026-08-28 | +55.9% exit |
| 2017-11-06 | HALO | SELL | $500K–$1.0M | $17.01 | $105.35 2026-08-28 | -519.3% exit |
| 2017-10-18 | ZIOP | SELL | $250K–$500K | — | — | — exit |
| 2017-10-18 | XON | SELL | $1.0M–$5.0M | — | — | — exit |
| 2016-10-11 | GSK | BUY | $1K–$15K | $42.14 | $50.82 2026-08-28 | +20.6% |
| 2011-02-27 | MSFT | SELL | $15K–$50K | $26.55 | $513.53 2026-08-28 | -1834.2% exit |
| 2011-02-01 | IBM | BUY | $1K–$15K | $156.37 | $235.59 2026-08-28 | +50.7% |
Buys are marked to the latest close and treated as still open. A sell tagged rt closes an earlier disclosed buy in the same name. exit reads from the seller's side: how the stock moved after they were out.
| Member | Shared tickers |
|---|---|
| Alan S. Lowenthal | 4 · IBM, MSFT, CHTR, ZAYO |
| K. Michael Conaway | 4 · GSK, IBM, MSFT, CHTR |
| Kurt Schrader | 4 · GSK, IBM, MSFT, CHTR |
| Rohit Khanna | 4 · GSK, IBM, MSFT, CHTR |
| George Holding | 4 · GSK, IBM, MSFT, CHTR |
| Josh Gottheimer | 3 · IBM, MSFT, HALO |
| Thomas H Tuberville | 3 · GSK, IBM, MSFT |
| Thomas R Carper | 3 · GSK, IBM, MSFT |
| John Boozman | 3 · GSK, IBM, MSFT |
| Alan Armstrong | 3 · IBM, MSFT, CHTR |
| David P. Roe | 3 · GSK, IBM, MSFT |
| DIANNE FEINSTEIN | 3 · IBM, MSFT, CHTR |